Course Summary
Contact Hour(s):
4 Contact Hours, including 4 Advanced Pharmacology Hours
Author:
Berthina Coleman, MD, BSN, RN
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner
Accreditations:
The American Nurses Credentialing Center (ANCC)
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353
Course Description:
The purpose of this course is to enable the participants to get an in-depth understanding of chronic kidney disease, review its staging, and understand the relationship with its main comorbidities and how these comorbidities affect patient outcomes.
We will also review the management of patients with chronic kidney disease. The learner will garner a better understanding of how to manage complications occurring during dialysis, better comprehend the pharmacokinetics and pharmacodynamics in patients with CKD, and finally, a brief review of the role that nurses (both dialysis and non-dialysis nurses) play in caring for patients with chronic kidney disease.
Outcomes
≥ 92% of participants will know how to stage and manage chronic kidney disease.
Objectives
After completing this continuing education course, the participant will be able to:
- Define Chronic Kidney Disease.
- Outline the staging of chronic kidney disease.
- Identify the gold standard for the treatment of end-stage renal failure.
- Identify the two main comorbidities associated with chronic kidney disease.
- Categorize the etiology and treatment of intradialytic hypotension.
- Relate the three causes of allergic reactions to dialyzers.
- Explain the cause of dialysis disequilibrium syndrome.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.